Registration for PeproTech.com is no longer available. To order your PeproTech products online, register or logon to ThermoFisher.com.
Resources & Support
References
First Author
Kazantseva, J
Title
Graphene-augmented nanofiber scaffolds demonstrate new features in cells behaviour.
Citation
Scientific Reports; 2016 Jul 22; 6 pg30150
PubMed ID
First Author
Burzynski, L C
Title
Interleukin-1α Activity in Necrotic Endothelial Cells Is Controlled by Caspase-1 Cleavage of Interleukin-1 Receptor-2: IMPLICATIONS FOR ALLOGRAFT REJECTION.
Citation
The Journal of Biological Chemistry; 2015 Oct 9; 290(41) pg25188-96
PubMed ID
First Author
Suárez-Álvarez, K
Title
Serum IL-12 is increased in Mexican obese subjects and associated with low-grade inflammation and obesity-related parameters.
Citation
Mediators of Inflammation; 2013; 2013 pg967067
PubMed ID
First Author
Zheng, Y
Title
Intracellular interleukin-1 receptor 2 binding prevents cleavage and activity of interleukin-1α, controlling necrosis-induced sterile inflammation.
Citation
Immunity; 2013 Feb 21; 38(2) pg285-95
PubMed ID
First Author
Giordano Attianese, G M
Title
In vitro and in vivo model of a novel immunotherapy approach for chronic lymphocytic leukemia by anti-CD23 chimeric antigen receptor.
Citation
Blood; 2011 May 5; 117(18) pg4736-45
PubMed ID
Product Cited
Cross-Reactivity
Applications
First Author
Vossenkämper, A
Title
Inhibition of NF-κB signaling in human dendritic cells by the enteropathogenic Escherichia coli effector protein NleE.
Citation
Journal of immunology (Baltimore, Md. : 1950); 2010 Oct 1; 185(7) pg4118-27
PubMed ID
First Author
De Wall, S L
Title
Noble metals strip peptides from class II MHC proteins.
Citation
Nature Chemical Biology; 2006 Apr; 2(4) pg197-201
PubMed ID
Product Cited
Cross-Reactivity
Applications
showing 7 of 7
Quick Order: Upload CSV Instructions
Navigate to the CSV file of PeproTech products on your computer. Click on the file name to highlight it. Then, click "Open" in the dialog box. Items will load on the Quick Order form.
Coming Soon
This feature is coming soon.